|
YALE COMPREHENSIVE CANCER CENTER
|
5P30CA016359-30
|
$1,889,710
|
$56,691
|
EDELSON, RICHARD
|
YALE UNIVERSITY
|
|
WUMC-Cancer and Leukemia Group B
|
5U10CA077440-11
|
$334,932
|
$10,048
|
BARTLETT, NANCY
|
WASHINGTON UNIVERSITY
|
|
Workshops on Viral Pathogenesis and Oncogenesis
|
5R13CA095919-07
|
$9,000
|
$2,250
|
FAN, HUNG
|
UNIVERSITY OF CALIFORNIA IRVINE
|
|
West Coast AIDS and Cancer Specimen Resource (ACSR)
|
2U01CA066529-14
|
$1,173,954
|
$293,489
|
MCGRATH, MICHAEL
|
UNIVERSITY OF CALIFORNIA SAN FRANCISCO
|
|
Washington University Molecular Imaging Center
|
5P50CA094056-08
|
$1,596,254
|
$526,764
|
PIWNICA-WORMS, David
|
WASHINGTON UNIVERSITY
|
|
VIRUS-HOST INTERACTIONS IN CANCER
|
5T32CA009031-32
|
$306,523
|
$30,652
|
KIEFF, ELLIOTT
|
HARVARD UNIVERSITY (MEDICAL SCHOOL)
|
|
Virginia Mason Community Clinical Oncology Program
|
5U10CA035192-25
|
$453,250
|
$9,065
|
Vuky, Jacqueline
|
BENAROYA RESEARCH INST AT VIRGINIA MASON
|
|
Viral Oncology Training Grant
|
2T32CA009111-31A2
|
$318,261
|
$63,652
|
CULLEN, BRYAN
|
DUKE UNIVERSITY
|
|
Viral and cellular gene regulation during lytic KSHV replication
|
5R01CA119905-03
|
$223,497
|
$111,749
|
Swaminathan, Sankar
|
UNIVERSITY OF FLORIDA
|
|
Veterans Administration hospitalization database, Patient Treatment File, and Out
|
Z01 CP010183-00580
|
$179,292
|
$17,929
|
Anderson, William
|
DCEG (NCI)
|
|
VCU Minority-Based CCOP
|
5U10CA052784-18
|
$577,110
|
$11,542
|
ROBERTS, JOHN
|
VIRGINIA COMMONWEALTH UNIVERSITY
|
|
UW Comprehensive Cancer Center Support
|
3P30CA014520-35S1
|
$59,955
|
$4,197
|
WILDING, GEORGE
|
UNIVERSITY OF WISCONSIN MADISON
|
|
UW Comprehensive Cancer Center Support
|
5P30CA014520-35
|
$4,795,480
|
$335,684
|
WILDING, GEORGE
|
UNIVERSITY OF WISCONSIN MADISON
|
|
UV/Vit D in radiologic technologists
|
Z01 CP010133-10416
|
$24,579
|
$3,687
|
Linet, Martha
|
DCEG (NCI)
|
|
UV-Dosimetry
|
Z01 CP010135-10262
|
$12,966
|
$2,593
|
Inskip, Peter
|
DCEG (NCI)
|
|
UT M.D. Anderson Cancer Center
|
5U10CA045809-20
|
$1,758,769
|
$17,588
|
FISCH, MICHAEL
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
USE OF mTOR INHIBITORS IN B CELL LEUKEMIA
|
5R01CA102646-04
|
$311,617
|
$102,834
|
GRUPP, STEPHAN
|
CHILDREN'S HOSPITAL OF PHILADELPHIA
|
|
USC/NORRIS COMPREHENSIVE CANCER CENTER (CORE) SUPPORT
|
3P30CA014089-33S1
|
$74,165
|
$4,450
|
JONES, PETER
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
USC/NORRIS COMPREHENSIVE CANCER CENTER (CORE) SUPPORT
|
5P30CA014089-33
|
$6,658,653
|
$399,519
|
JONES, PETER
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
UPSTATE CAROLINA COMMUNITY CLINICAL ONCOLOGY PROGRAM
|
5U10CA035119-24
|
$1,880,470
|
$37,609
|
BEARDEN, JAMES
|
SPARTANBURG REGIONAL MEDICAL CENTER
|
|
UNRESOLVED PUBLIC HEALTH ISSUES RELATED TO HT AND CANCER
|
5P01CA017054-30
|
$2,034,926
|
$691,875
|
HENDERSON, BRIAN
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
UNMC Eppley Cancer Center Support Grant
|
3P30CA036727-24S1
|
$80,987
|
$17,007
|
COWAN, KENNETH
|
UNIVERSITY OF NEBRASKA MEDICAL CENTER
|
|
UNMC Eppley Cancer Center Support Grant
|
5P30CA036727-24
|
$1,553,887
|
$326,316
|
COWAN, KENNETH
|
UNIVERSITY OF NEBRASKA MEDICAL CENTER
|
|
University of Rochester Cancer Center CCOP Research Base
|
3U10CA037420-24S1
|
$46,973
|
$4,697
|
Morrow, Gary
|
UNIVERSITY OF ROCHESTER
|
|
University of Rochester Cancer Center CCOP Research Base
|
5U10CA037420-24
|
$1,338,526
|
$133,853
|
Morrow, Gary
|
UNIVERSITY OF ROCHESTER
|
|
University of Michigan Comprehensive Cancer Center Support Grant
|
3P30CA046592-21S1
|
$61,058
|
$1,221
|
WICHA, MAX
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
|
University of Michigan Comprehensive Cancer Center Support Grant
|
5P30CA046592-21
|
$5,994,681
|
$119,894
|
WICHA, MAX
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
|
University of Maryland Greenebaum Cancer Center Support Grant
|
1P30CA134274-01
|
$1,463,613
|
$29,272
|
CULLEN, KEVIN
|
UNIVERSITY OF MARYLAND BALTIMORE
|
|
University of Iowa CALGB Institutional Grant
|
5U10CA047642-21
|
$110,413
|
$3,312
|
VAENA, DANIEL
|
UNIVERSITY OF IOWA
|
|
University of Colorado Southwest Oncology Group
|
3U10CA042777-21S1
|
$420,576
|
$42,058
|
ELIAS, ANTHONY
|
UNIVERSITY OF COLORADO DENVER
|
|
University of Colorado Southwest Oncology Group
|
5U10CA042777-21
|
$82,101
|
$8,210
|
ELIAS, ANTHONY
|
UNIVERSITY OF COLORADO DENVER
|
|
Understanding the Role of Autophagy in Cancer
|
5F32CA123777-03
|
$51,278
|
$51,278
|
DORSEY, FRANK
|
SCRIPPS RESEARCH INSTITUTE
|
|
Uncoupling of Jak/STAT in HTLV-1 associated leukemia
|
5R01CA115398-02
|
$223,440
|
$111,720
|
NICOT, CHRISTOPHE
|
UNIVERSITY OF KANSAS MEDICAL CENTER
|
|
UMB/DFHCC Comprehensive Cancer Partnership Program
|
5U56CA118635-04
|
$429,888
|
$85,978
|
Colon-Carmona, Adan
|
UNIVERSITY OF MASSACHUSETTS BOSTON
|
|
UCB-DERIVED CD19-SPECIFIC T CELLS FOR UNIVERSAL TREATMENT OF B-CELL MALIGNANCY
|
5R21CA116127-02
|
$168,750
|
$84,375
|
COOPER, LAURENCE
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
U10 Ful Member Application Affiliated with SWOG
|
5U10CA105409-05
|
$71,573
|
$7,157
|
LIPPMAN, SCOTT
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
Tumor Suppressor Protein, p53
|
Z01 BC 005599
|
$589,066
|
$147,267
|
Appella, Ettore
|
CCR (NCI)
|
|
Tumor Banking for the Southwest Oncology Group
|
5U24CA114748-04
|
$1,061,839
|
$106,184
|
BAKER, LAURENCE
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
|
Treatment of Infections in Immunocompromised Children
|
Z01 SC 006830
|
$1,957,171
|
$195,717
|
Walsh, Thomas
|
CCR (NCI)
|
|
Transplant Models
|
Z01 BC 010957
|
$530,539
|
$265,270
|
Gress, Ronald
|
CCR (NCI)
|
|
Translational Studies of the Histone Deacetylase Inhibitor Romidepsin
|
Z01 BC 010621
|
$569,585
|
$569,585
|
Bates, Susan
|
CCR (NCI)
|
|
Transformation of Cells by the REL Oncogene
|
3R01CA047763-20S1
|
$10,000
|
$10,000
|
GILMORE, THOMAS
|
BOSTON UNIVERSITY
|
|
Transformation of Cells by the REL Oncogene
|
5R01CA047763-21
|
$275,637
|
$275,637
|
GILMORE, THOMAS
|
BOSTON UNIVERSITY
|
|
Transformation by Reticuloendotheliosis Virus
|
5R01CA033192-21
|
$302,573
|
$302,573
|
BOSE, HENRY
|
UNIVERSITY OF TEXAS AUSTIN
|
|
Transcriptional silencing by the Bcl-6 oncoprotein
|
5R01CA104348-05
|
$259,688
|
$259,688
|
MELNICK, ARI
|
YESHIVA UNIVERSITY
|
|
Training Patients and Partners for HSCT: A Novel Coping Skills Intervention
|
5R03CA130725-02
|
$84,500
|
$42,250
|
Lawsin, Catalina
|
BERNARD M. BARUCH COLLEGE
|
|
Training in Tumor Virology
|
5T32CA115299-03
|
$229,654
|
$45,931
|
ROBERTSON, ERLE
|
UNIVERSITY OF PENNSYLVANIA
|
|
Toll Receptor Ligand Therapy of Cutaneous T-Cell Lymphoma
|
1R01CA122569-01A2
|
$283,500
|
$141,750
|
ROOK, ALAIN
|
UNIVERSITY OF PENNSYLVANIA
|
|
TOLEDO COMMUNITY CLINICAL ONCOLOGY PROGRAM
|
5U10CA035415-25
|
$721,858
|
$7,219
|
SCHAEFER, PAUL
|
TOLEDO COMMUNITY HOSPITAL ONCOLOGY PROG
|
|
Therapy of Lymphoma/Leukemia with Monoclonal Antibodies
|
5P01CA044991-21
|
$1,944,619
|
$972,310
|
Press, Oliver
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
Total relevant funding to Non Hodgkins Lymphoma for this search: $122,611,027
|